SEC Form D private-offering filing
PERSISTA BIO INC.
A new SEC Form D private-offering notice from City Of Lewes, DE, an undisclosed offering target in Biotech. The source filing is one click away.
Biotechnology company developing an implantable cell therapy device that automatically regulates blood sugar to treat type 1 diabetes without daily injections.
Filed 2026-04-29Filed to raise UndisclosedFirst money in 2026-04-14HQ (as filed) City Of Lewes, DESector Biotech ✓Stage (inferred) IndeterminateCall status No reported sale
Source linked the Form D on EDGAR↗Website verified persistabio.com↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.